02570nam 2200577Ia 450 991014467350332120170816124457.01-282-34262-297866123426220-470-69929-90-470-69869-1(CKB)1000000000687650(EBL)470765(OCoLC)609849811(SSID)ssj0000289320(PQKBManifestationID)11241160(PQKBTitleCode)TC0000289320(PQKBWorkID)10404620(PQKB)11262555(MiAaPQ)EBC470765(EXLCZ)99100000000068765019910628d1991 uy 0engur|n|---|||||txtccrAssessment & management of emotional reactions to brain damage & aphasia[electronic resource] /Peter WährborgSan Diego Singular Publishing Groupc19911 online resource (126 p.)Far communication disorders seriesDescription based upon print version of record.0-9514728-3-6 Includes bibliographical references (p. 104-112) and index.ASSESSMENT & MANAGEMENT OF EMOTIONAL REACTIONS TO BRAIN DAMAGE & APHASIA; CONTENTS; Preface; Chapter 1 Introduction; Chapter 2 Aphasia and Behaviour; Chapter 3 Aphasia and the Family; Chapter 4 Towards a Model of Psychological Reactions to Brain Damage and Aphasia; Chapter 5 The Assessment of Emotional and Psychosocial Disorder in Aphasic Individuals and Their Families; Chapter 6 Management and Treatment of Psychological and Social Problems in Aphasics and Their Families; Chapter 7 Long-term Evolution of Psychosocial and Emotional State; References; IndexAims to provide an accessible and practical guide to the assessment, differentiation and clinical management of the emotional and psychosocial problems of aphasic and non-aphasic brain damaged individuals and their families. Current clinical approaches are also considered.Far communication disorders series.AphasiaBrain damageElectronic books.Aphasia.Brain damage.616.855206Währborg Peter969045MiAaPQMiAaPQMiAaPQBOOK9910144673503321Assessment & management of emotional reactions to brain damage & aphasia2201529UNINA04144 am 2200745 n 450 991031194830332120190206979-1-03-440439-110.4000/books.pus.10941(CKB)4100000007702284(FrMaCLE)OB-pus-10941(oapen)https://directory.doabooks.org/handle/20.500.12854/62054(PPN)234838329(EXLCZ)99410000000770228420190226j|||||||| ||| 0freuu||||||m||||txtrdacontentcrdamediacrrdacarrierVictorien Sardou, un siècle plus tard /Guy DucreyStrasbourg Presses universitaires de Strasbourg20191 online resource (416-XXXII p.) 2-86820-346-9 Dans la deuxième moitié du xixe siècle, Victorien Sardou (1831-1908) fut l'ambassadeur officieux de la culture française à l'étranger, grâce notamment à sa muse Sarah Bernhardt, pour qui il écrivit sept pièces. En quarante ans de carrière, il parvint à déployer des talents variés : tour à tour, ou simultanément, auteur de féeries, de vaudevilles, de comédies de mœurs, de satires sociales, de drames historiques ou psychologiques, il fut aussi metteur en scène, décorateur à ses heures, agent littéraire et promoteur de spectacles. Un homme de théâtre, dans l'acception plurielle que l'expression recouvrait au xixe siècle, et jusqu'à Cocteau. Mais cet éclectisme, et plus encore le suffrage du grand public, valurent à l'auteur de solides inimitiés, et un mépris persistant. Ce n'est pas le moindre intérêt de son œuvre que d'avoir servi de repoussoir aux poètes et dramaturges de l'avant-garde, notamment symboliste. Aujourd'hui que l'on commémore le centenaire de la disparition de l'auteur, il est possible de jeter un regard renouvelé sur son œuvre - sur des spectacles qui marquèrent à maints égards l'apogée du xixe siècle au théâtre, mais qui, peu avant l'arrivée du cinéma, semblaient aussi annoncer le siècle à venir. Comment considérer, à un siècle de distance, la production de Sardou ? Et son travail de mise en scène ? Comment les articuler surtout avec la création théâtrale du xixe siècle finissant ? Et avec celle d'un xxe siècle que Sardou connut à peine ? Telles sont les questions développées par ce livre - le premier à projeter des feux croisés sur celui qui s'était tenu, durant un demi-siècle, au centre de la scène théâtrale européenne.Literature, RomancethéâtreXIXe sièclethéâtreXIXe siècleLiterature, RomancethéâtreXIXe siècleBenay Jeanne1306546Benhamou Noëlle1306547Besnier Patrick329185Chevrel Yves175128David-de Palacio Marie-France1306548Dethurens Pascal176077Dubar Monique1285943Ducrey Guy1278383Dufief Anne-Simone169482D’Andrea Patrizia1306549Ergal Yves-Michel1298808Gay Ignacio Ramos1304827Goetz Olivier1306550Humbert-Mougin Sylvie1306551Jolly Geneviève1306552Krakovitch Odile1306553Laplace-Claverie Hélène389009Lormier Céline1306554Lucet Sophie1278386Marchadier Aline1306555Moindrot Isabelle1305890Picard Timothée1306556Santos Ana Clara1291626Strich Marie-José1306557Victoroff Tatiana1257387Yon Jean-Claude778658Ducrey Guy1278383FR-FrMaCLEBOOK9910311948303321Victorien Sardou, un siècle plus tard3028501UNINA05061nam 2201321z- 450 991036774590332120231214133007.03-03921-707-0(CKB)4100000010106258(oapen)https://directory.doabooks.org/handle/20.500.12854/51774(EXLCZ)99410000001010625820202102d2019 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierLinks between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic ChallengesMDPI - Multidisciplinary Digital Publishing Institute20191 electronic resource (348 p.)3-03921-706-2 Tissue fibrosis may occur for unknown causes or be the consequence of many pathological conditions including chronic inflammatory or infectious diseases, autoimmune disorders, graft rejection, or malignancy. On the other hand, malignant tumors have been identified in fibrotic tissues decades ago, and now accumulating evidence suggests that fibrotic lesions enhance the risk of cancer in several organs such as liver, lungs, and breast. Disruption of an organ parenchymal cells and of its normal structural scaffold during tissue fibrogenesis appears to induce loss of cell polarity, promoting uncontrolled cell proliferation that may eventually lead to cancer development. Many cellular and molecular abnormalities including aberrant expression of microRNAs, genetic and epigenetic alterations, evasion or delayed apoptosis, unregulated intracellular signal pathways, and dysregulation or defective intercellular communications have been proposed to explain this link between fibrogenesis and carcinogenesis. However, the precise mechanisms of this fibrosis-to-cancer transition remain unclear. This book presents a collection of reviews and original articles summarizing recent advances in understanding the molecular mechanisms of cancer development in fibrotic organs.Links between Fibrogenesis and Cancerbleomycinregenerationantitumor efficacylung cancerSOX2leiomyosarcomalung cancer (LC)nanoparticlescytokineshepatocellular carcinomametabolic reprogramminghepatic stellate cellsangiogenesistransforming growth factor-?anaplastic lymphoma kinaseidiopathic pulmonary fibrosisgrowth factorpathogenesiscancer-associated fibroblastsfibrosislipopolysaccharideDHAlncRNASREBP-1YAPprotein Snon-small cell lung cancer (NSCLC)omega-3 fatty acidinflammationmetastasisclinical symptomsmiRNAsmooth muscle tumor of uncertain malignant potentialWntinterstitial fluid pressureheterogeneityhepatocytesmyometriumtumor necrosis factor ?tumortumor microenvironmentextracellular matrixTAZcarcinogenesiscystic formationpulmonary fibrosisHBVcytokinegenetic instabilitydiagnosisEMTcrizotinibHippo pathwayGPR120markerHCVnon-alcoholic steatohepatitispathologycommon pathwaysapoptosistype I collagenGPR40acute lung injuryuterine fibroidrenal injurypathophysiologyreactive oxygen speciesimmunohistochemistrySMADbutylidenephthalideleiomyomacirrhosisErk1/2targeted therapyTGF-?mechanotransductiontherapybreast cancerhepatocellular carcinoma (HCC)hepatic stellate cells (HSCs)idiopathic pulmonary fibrosis (IPF)cancer-associated fibroblasts (CAFs)cancersignal pathwaytumor stiffnessGabazza Esteban Cauth1288168BOOK9910367745903321Links between Fibrogenesis and Cancer: Mechanistic and Therapeutic Challenges: Mechanistic and Therapeutic Challenges3020666UNINA